Rufinamide Suspension
Product Images NDC 72603-261

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Rufinamide (NDC 72603-261). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rufinamideoscartonlabel (Rufinamideoscartonlabel)

Rufinamide Oral Suspension 40 mg/mL label for a 460 mL bottle. The label states it is for oral administration only, supplied with two 20 mL syringes. It has storage instructions, a Pharmacist advisory for dispensing the Medication Guide, and manufacturing details for NorthStar Rx LLC and Hetero Labs Limited, India.*

FDA Label Image

Rufinamideoschemicalstructure (Rufinamideoschemicalstructure)

Chemical structure diagram of Rufinamide, displaying its molecular framework with fluorine atoms, a carbonyl group, and nitrogen-containing rings consistent with its chemical composition.*

FDA Label Image

Rufinamideoscontainerlabel (Rufinamideoscontainerlabel)

Label for Rufinamide Oral Suspension 40 mg/mL, a prescription oral suspension manufactured for NorthStar Rx LLC. The label includes dosage strength, storage instructions (20° to 25°C), a note to shake the bottle before use, and mentions dispensing a medication guide. Manufactured by Hetero Labs Limited, India, with a 460 mL volume indicated.*

FDA Label Image

Rufinamideosfigurea (Rufinamideosfigurea)

An instructional illustration labeled Figure A depicting components of an oral medication administration set: a bottle, a box, a bottle adapter, and two syringes. The image is likely intended to show how these parts fit together for dispensing the liquid medication.*

FDA Label Image

Rufinamideosfigureb (Rufinamideosfigureb)

An instructional illustration labeled Figure B demonstrating how to shake an oral suspension bottle well before use. The image shows a hand holding a bottle with an arrow indicating a shaking motion.*

FDA Label Image

Rufinamideosfigurec (Rufinamideosfigurec)

An instructional diagram labeled Figure C showing a bottle adapter component designed for use with a medication bottle.*

FDA Label Image

Rufinamideosfigured (Rufinamideosfigured)

An instructional illustration labeled Figure D shows a hand gripping and pressing down on the cap of a bottle, with a downward arrow indicating the direction to push or press the cap. This likely demonstrates how to open or close the bottle.*

FDA Label Image

Rufinamideosfiguree (Rufinamideosfiguree)

Illustration showing a syringe with a plunger and volume markings from 15 mL to 20 mL, including a magnified inset highlighting the measurement graduations on the syringe barrel. This is likely related to dosing or measurement instructions for the Rufinamide oral suspension.*

FDA Label Image

Rufinamideosfiguref (Rufinamideosfiguref)

An instructional illustration labeled Figure F showing a hand holding a syringe above a bottle, with a downward arrow indicating the syringe should be pushed down into the bottle. This image likely demonstrates drawing the Rufinamide oral suspension from the bottle using the syringe.*

FDA Label Image

Rufinamideosfigureg (Rufinamideosfigureg)

An instructional illustration labeled Figure G showing a hand holding a syringe used to withdraw liquid from a bottle, with an arrow indicating downward motion. It appears to demonstrate the proper technique for drawing oral suspension medication.*

FDA Label Image

Rufinamideosfigureh (Rufinamideosfigureh)

An instructional diagram showing a hand holding a syringe with a plunger, measuring liquid medicine up to 5 mL. The illustration highlights the proper measurement to the violet end of the plunger for accurate dosing.*

FDA Label Image

Rufinamideosfigurei (Rufinamideosfigurei)

An instructional illustration showing a person administering an oral suspension using an oral syringe. The person is placing the syringe into their mouth to deliver the liquid medication. This diagram is likely related to the administration of Rufinamide oral suspension.*

FDA Label Image

Rufinamideosfigurej (Rufinamideosfigurej)

An instructional illustration depicting the use of an oral syringe to measure and administer a liquid medication suspension. The left side shows a hand drawing liquid from a cup into the syringe, while the right side shows the syringe being held downward, dispensing the medication.*

FDA Label Image

Rufinamideosfigurek (Rufinamideosfigurek)

An instructional illustration showing a hand opening the cap of a bottle, demonstrating the proper method to twist or lift the cap to access the contents inside. This likely relates to the oral suspension bottle closure mechanism.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.